Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of duloxetine on anxiety and depression in patients with diabetic neuropathy
IRCT20210725051977N2Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of duloxetine in diabetic neuropathy, anxiety disorder and major depressive disorder (MDD), sponsored by Islamic Azad University. Started May 2022; status: completed.
02
Drugs
duloxetine
03
Conditions
diabetic neuropathyanxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20210725051977N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210725051977N2.